Skip to content

Medpace Voice

Tag: CAR-T

Clinical Development

4 Key Considerations for Designing Immuno-Oncology Trials

  • July 22, 2019

As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…

Central Laboratories

The Current Biomarker Landscape in Immuno-Oncology

  • June 13, 2019

Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.

Clinical Development

Medpace’s Focus on Hematology and Oncology Aligns with Innovative Biotechs

  • February 13, 2019

Europe is a vital contributor to a new wave of technology that is changing the face of treatments and clinical development